HIP
REGN icon

HUB Investment Partners’s Regeneron Pharmaceuticals REGN Stock Holding History

HUB Investment Partners’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-3,800
Closed -$2.3M – 235
2021
Q3 		$2.3M Buy
+3,800
New +$2.36M 0.55% 49

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

HUB Investment Partners's REGN Position: Q2 2026 in Review

HUB Investment Partners increased its Regeneron Pharmaceuticals (REGN) stake by 76% in Q2 2026, buying an estimated $612K and bringing the position to 2,079 shares worth $1.3M. The position accounts for 0.02% of the portfolio, ranked #389.

HUB Investment Partners first reported a position in REGN in Q4 2025 and has held it in 3 quarters since. 729 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • HUB Investment Partners held 2,079 shares of Regeneron Pharmaceuticals worth $1.3M as of Q2 2026.
  • HUB Investment Partners bought 899 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $612K.
  • Regeneron Pharmaceuticals made up 0.02% of HUB Investment Partners's portfolio in Q2 2026, its #389 holding.
  • HUB Investment Partners first reported a position in Regeneron Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 729 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on HUB Investment Partners's 13F filing for Q2 2026, filed 31 Jul 2026.